Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARMSTRONG J. B., WHITE J. C. Liquefaction of viscous purulent exudates by deoxyribonuclease. Lancet. 1950 Dec 9;2(6641):739–742. doi: 10.1016/s0140-6736(50)91676-x. [DOI] [PubMed] [Google Scholar]
- Aitken M. L., Burke W., McDonald G., Shak S., Montgomery A. B., Smith A. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA. 1992 Apr 8;267(14):1947–1951. [PubMed] [Google Scholar]
- CHERNICK W. S., BARBERO G. J. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics. 1959 Nov;24:739–745. [PubMed] [Google Scholar]
- ELMES P. C., WHITE J. C. Deoxyribonuclease in the treatment of purulent bronchitis. Thorax. 1953 Dec;8(4):295–300. doi: 10.1136/thx.8.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs H. J., Borowitz D. S., Christiansen D. H., Morris E. M., Nash M. L., Ramsey B. W., Rosenstein B. J., Smith A. L., Wohl M. E. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994 Sep 8;331(10):637–642. doi: 10.1056/NEJM199409083311003. [DOI] [PubMed] [Google Scholar]
- Fuchs H. J., Borowitz D. S., Christiansen D. H., Morris E. M., Nash M. L., Ramsey B. W., Rosenstein B. J., Smith A. L., Wohl M. E. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994 Sep 8;331(10):637–642. doi: 10.1056/NEJM199409083311003. [DOI] [PubMed] [Google Scholar]
- Hubbard R. C., McElvaney N. G., Birrer P., Shak S., Robinson W. W., Jolley C., Wu M., Chernick M. S., Crystal R. G. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med. 1992 Mar 19;326(12):812–815. doi: 10.1056/NEJM199203193261207. [DOI] [PubMed] [Google Scholar]
- Potter J. L., Matthews L. W., Spector S., Lemm J. Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions. Pediatrics. 1965 Nov;36(5):714–720. [PubMed] [Google Scholar]
- Ramsey B. W., Astley S. J., Aitken M. L., Burke W., Colin A. A., Dorkin H. L., Eisenberg J. D., Gibson R. L., Harwood I. R., Schidlow D. V. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis. 1993 Jul;148(1):145–151. doi: 10.1164/ajrccm/148.1.145. [DOI] [PubMed] [Google Scholar]
- Ranasinha C., Assoufi B., Shak S., Christiansen D., Fuchs H., Empey D., Geddes D., Hodson M. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet. 1993 Jul 24;342(8865):199–202. doi: 10.1016/0140-6736(93)92297-7. [DOI] [PubMed] [Google Scholar]
- SALOMON A., HERCHFUS J. A., SEGAL M. S. Aerosols of pancreatic dornase in bronchopulmonary disease. Ann Allergy. 1954 Jan-Feb;12(1):71–77. [PubMed] [Google Scholar]
- SPIER R., WITEBSKY E., PAINE J. R. Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections. JAMA. 1961 Dec 2;178:878–886. doi: 10.1001/jama.1961.03040480008003. [DOI] [PubMed] [Google Scholar]
- Shah P. L., Scott S. F., Fuchs H. J., Geddes D. M., Hodson M. E. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax. 1995 Apr;50(4):333–338. doi: 10.1136/thx.50.4.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shak S., Capon D. J., Hellmiss R., Marsters S. A., Baker C. L. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9188–9192. doi: 10.1073/pnas.87.23.9188. [DOI] [PMC free article] [PubMed] [Google Scholar]